MGAT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.249600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.954600E-01
Normal-vs-Stage2
8.519000E-01
Normal-vs-Stage3
3.689600E-01
Normal-vs-Stage4
3.737400E-01
Stage1-vs-Stage2
2.382200E-01
Stage1-vs-Stage3
8.317200E-01
Stage1-vs-Stage4
8.570200E-02
Stage2-vs-Stage3
2.500600E-01
Stage2-vs-Stage4
3.140400E-01
Stage3-vs-Stage4
1.246160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.369600E-01
Normal-vs-AfricanAmerican
7.344600E-01
Normal-vs-Asian
5.202800E-01
Caucasian-vs-AfricanAmerican
5.392600E-01
Caucasian-vs-Asian
2.115000E-01
AfricanAmerican-vs-Asian
2.499800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.037600E-01
Normal-vs-Female
9.501600E-01
Male-vs-Female
7.423200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.339000E-01
Normal-vs-Age(41-60Yrs)
6.641600E-01
Normal-vs-Age(61-80Yrs)
9.427800E-01
Normal-vs-Age(81-100Yrs)
6.784800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.987000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.589000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.624800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.072400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.444200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.956200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.304600E-01
Normal-vs-Daily Drinker
4.415600E-01
Normal-vs-Weekly Drinker
8.466800E-01
Normal-vs-Occasional Drinker
5.950800E-01
Normal-vs-Social Drinker
9.787800E-01
Non Drinker-vs-Daily Drinker
3.655000E-01
Non Drinker-vs-Weekly Drinker
3.228600E-01
Non Drinker-vs-Occasional Drinker
1.084430E-01
Non Drinker-vs-Social Drinker
5.285000E-01
Daily Drinker-vs-Weekly Drinker
1.173580E-01
Daily Drinker-vs-Occasional Drinker
4.292400E-02
Daily Drinker-vs-Social Drinker
1.598570E-01
Weekly Drinker-vs-Occasional Drinker
4.419000E-01
Weekly Drinker-vs-Social Drinker
6.809800E-01
Occasional Drinker-vs-Social Drinker
2.207400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.167000E-01
Normal-vs-Grade 2
7.944200E-01
Normal-vs-Grade 3
7.864200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.079900E-02
Grade 1-vs-Grade 3
6.741900E-02
Grade 1-vs-Grade 4
9.167000E-01
Grade 2-vs-Grade 3
8.767200E-01
Grade 2-vs-Grade 4
7.944200E-01
Grade 3-vs-Grade 4
7.864200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.061600E-01
Normal-vs-NonDiabetic
9.894000E-01
Diabetic-vs-NonDiabetic
6.878200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.528650E-01
Normal-vs-NoPancreatitis
9.176600E-01
Pancreatitis-vs-NoPancreatitis
2.971700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.656000E-01
Normal-vs-N1
8.273000E-01
N0-vs-N1
1.940960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.012200E-01
Normal-vs-TP53-NonMutant
9.170400E-01
TP53-Mutant-vs-TP53-NonMutant
8.674200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
